Sterically Stabilized Phospholipid Mixed Micelles: in Vitro Evaluation As a Novel Carrier for Water-insoluble Drugs

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2003 Mar 15

PMID 12636171

Citations 42

Authors

Aparna Krishnadas

Israel Rubinstein

Hayat Onyuksel

Affiliations

Soon will be listed here.

Abstract

Purpose: Sterically stabilized phospholipid micelles (SSMs) composed of poly(ethylene glycol-2000)-grafted distearoyl phosphatidylethanolamine (PEG(2000)-DSPE) are new and promising lipid-based carriers for water-insoluble drugs. This study investigates and compares sterically stabilized mixed micelles (SSMM), composed of (PEG(2000)-DSPE) plus egg-phosphatidylcholine, with SSM as a novel delivery system for improved solubilization of water-insoluble drugs using paclitaxel as a model.

Methods: Paclitaxel was solubilized in SSM (P-SSM) and SSMM (P-SSMM) by coprecipitation and rehydration with isotonic 0.01M HEPES buffer, pH 7.4. After separation of excess drug by centrifugation, mean particle size and morphology of particles in the supernatant were determined by quasi-elastic light scattering and transmission electron microscopy. The solubilization potentials of SSMM and SSM for paclitaxel were determined by reverse phase high pressure liquid chromatography (RP-HPLC). Cytotoxic activity of paclitaxel in SSMM. SSM, and dimethyl sulfoxide (10% DMSO) was determined against human breast cancer cells (MCF-7).

Results: Mean hydrodynamic diameter of P-SSMM and P-SSM were 13.1 +/- 1.1 nm and 15 +/- 1 nm (n = 3), respectively. SSMM solubilized 1.5 times more paclitaxel than SSM for the same total lipid concentration. Solubilized paclitaxel amount increased linearly with an increase in lipid concentration. A therapeutically relevant lipid concentration (15 mM) of SSMM solubilized 1,321 +/- 48 microg/ml of paclitaxel. Paclitaxel in the absence of sufficient SSM aggregated to form lipid-coated crystals. P-SSMM, P-SSM. and paclitaxel in DMSO had comparable cytotoxic activities against MCF-7 cells.

Conclusions: SSMM showed increased solubilization potential compared with SSM while retaining all of its own advantages. Therefore, it can be used as an improved lipid-based carrier for water-insoluble drugs.

Citing Articles

Long-Circulation and Brain Targeted Isoliquiritigenin Micelle Nanoparticles: Formation, Characterization, Tissue Distribution, Pharmacokinetics and Effects for Ischemic Stroke.

Song W, Bai L, Yang Y, Wang Y, Xu P, Zhao Y Int J Nanomedicine. 2022; 17:3655-3670.

PMID: 35999993 PMC: 9393037. DOI: 10.2147/IJN.S368528.

One-Pot, One-Step Synthesis of Drug-Loaded Magnetic Multimicelle Aggregates.

Kim C, Nevozhay D, Aburto R, Pehere A, Pang L, Dillard R Bioconjug Chem. 2022; 33(5):969-981.

PMID: 35522527 PMC: 9121875. DOI: 10.1021/acs.bioconjchem.2c00167.

Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids?.

Loh J, Tan L, Lee W, Ming L, How C, Foo J Cancers (Basel). 2021; 13(21).

PMID: 34771511 PMC: 8582402. DOI: 10.3390/cancers13215346.

PEGylation of Paclitaxel-Loaded Cationic Liposomes Drives Steric Stabilization of Bicelles and Vesicles thereby Enhancing Delivery and Cytotoxicity to Human Cancer Cells.

Steffes V, Zhang Z, MacDonald S, Crowe J, Ewert K, Carragher B ACS Appl Mater Interfaces. 2019; 12(1):151-162.

PMID: 31820904 PMC: 6984750. DOI: 10.1021/acsami.9b16150.

Why is glycocholic acid sodium salt better than deoxycholic acid sodium salt for the preparation of mixed micelle injections?.

Wang T, Shen L, Sun L, Zhang Y, Li H, Wang Y Food Sci Nutr. 2019; 7(11):3675-3680.

PMID: 31763016 PMC: 6848834. DOI: 10.1002/fsn3.1224.

References

Blajeski A, Kottke T, Kaufmann S . A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines. Exp Cell Res. 2001; 270(2):277-88. DOI: 10.1006/excr.2001.5349. View

van Zuylen L, Karlsson M, Verweij J, Brouwer E, de Bruijn P, Nooter K . Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles. Cancer Chemother Pharmacol. 2001; 47(4):309-18. DOI: 10.1007/s002800000215. View

Weissig V, Whiteman K, Torchilin V . Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm Res. 1998; 15(10):1552-6. DOI: 10.1023/a:1011951016118. View

Onyuksel H, Ikezaki H, Patel M, Gao X, Rubinstein I . A novel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo. Pharm Res. 1999; 16(1):155-60. DOI: 10.1023/a:1018847501985. View

Rex S, Zuckermann M, LaFleur M, Silvius J . Experimental and Monte Carlo simulation studies of the thermodynamics of polyethyleneglycol chains grafted to lipid bilayers. Biophys J. 1998; 75(6):2900-14. PMC: 1299962. DOI: 10.1016/S0006-3495(98)77732-X. View

Torchilin V . Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001; 73(2-3):137-72. DOI: 10.1016/s0168-3659(01)00299-1. View

Liu Y, Ali S, Boge T, Georg G, Victory S, Zygmunt J . A systematic SAR study of C10 modified paclitaxel analogues using a combinatorial approach. Comb Chem High Throughput Screen. 2002; 5(1):39-48. DOI: 10.2174/1386207023330615. View

Son K . Mixed micelles as proliposomes for the solubilization of teniposide. Pharm Res. 1992; 9(12):1556-62. DOI: 10.1023/a:1015804206414. View

Sharma A, Straubinger R . Novel taxol formulations: preparation and characterization of taxol-containing liposomes. Pharm Res. 1994; 11(6):889-96. DOI: 10.1023/a:1018994111594. View

10.

Kohler D, Goldspiel B . Paclitaxel (taxol). Pharmacotherapy. 1994; 14(1):3-34. DOI: 10.1002/j.1875-9114.1994.tb02785.x. View

11.

Sharma A, Mayhew E, Bolcsak L, Cavanaugh C, Harmon P, Janoff A . Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer. 1997; 71(1):103-7. DOI: 10.1002/(sici)1097-0215(19970328)71:1<103::aid-ijc17>3.0.co;2-j. View

12.

Belsito S, Bartucci R, Sportelli L . Lipid chain length effect on the phase behaviour of PCs/PEG:2000-PEs mixtures. A spin label electron spin resonance and spectrophotometric study. Biophys Chem. 2001; 93(1):11-22. DOI: 10.1016/s0301-4622(01)00201-0. View

13.

Working P, Dayan A . Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl). Hum Exp Toxicol. 1996; 15(9):751-85. View

14.

Ramakrishnan S, Chai H, Pezzuto J . A mixed micellar formulation suitable for the parenteral administration of taxol. Pharm Res. 1994; 11(2):206-12. DOI: 10.1023/a:1018943021705. View

15.

Balasubramanian S, Alderfer J, Straubinger R . Solvent- and concentration-dependent molecular interactions of taxol (Paclitaxel). J Pharm Sci. 1994; 83(10):1470-6. DOI: 10.1002/jps.2600831021. View

16.

Likhitwitayawuid K, Angerhofer C, Cordell G, Pezzuto J, Ruangrungsi N . Cytotoxic and antimalarial bisbenzylisoquinoline alkaloids from Stephania erecta. J Nat Prod. 1993; 56(1):30-8. DOI: 10.1021/np50091a005. View

17.

Terwogt J, Nuijen B, Huinink W, Beijnen J . Alternative formulations of paclitaxel. Cancer Treat Rev. 1997; 23(2):87-95. DOI: 10.1016/s0305-7372(97)90022-0. View